Profiel
Christopher Seiter worked as the Chief Financial Officer at Trevi Therapeutics, Inc. from 2018 to 2021.
Prior to that, he held the same position at Millendo Therapeutics, Inc. He also worked as MD & Head-Life Sciences Investment Banking at Bank of America Merrill Lynch (New York).
Seiter completed his undergraduate degree at the University of Rochester.
Eerdere bekende functies van Christopher Seiter
| Bedrijven | Functie | Einde |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Financieel Directeur/CFO | 02-04-2021 |
Bank of America Merrill Lynch (New York)
Bank of America Merrill Lynch (New York) Regional BanksFinance Provides corporate, investment banking and wealth management services | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Financieel Directeur/CFO | - |
Opleiding van Christopher Seiter
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Bank of America Merrill Lynch (New York)
Bank of America Merrill Lynch (New York) Regional BanksFinance Provides corporate, investment banking and wealth management services | Finance |
Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
















